Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
A Prospective Pilot Study to Evaluate the Safety and Efficacy of Botox™ for the Treatment of Men Diagnosed With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Sponsor: Allergan
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Allergan
Other Chronic Pain Syndrome trials with similar outcome
This PHASE1 trial investigates Chronic Pain Syndrome and Prostatitis and is currently terminated or withdrawn. Allergan leads this study, which shows 9 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE1
-
Apr 2025 — Jun 2025 [monthly]
Terminated PHASE1
-
Sep 2024 — Apr 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
▶ Show 4 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Terminated PHASE1
Status: Completed → Terminated · Phase: PHASE2 → PHASE1
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allergan
- Queen's University
For direct contact, visit the study record on ClinicalTrials.gov .